Revenue decline for Cell C’s major shareholder Blue Label
Cell C valued at R3.1bn after latest fund raise
Cell C recap deal earmarked for mid-September
Blue Label goes after execs behind R315m fraud
Airtime purchase deal with Investec, First Rand to refinance Cell C
Blue Label confident of Cell C recap, but no timelines
Blue Label expects positive turn in six-month results
Cell C’s recap lifeline close, says shareholder Blue Label
Blue Label back in the black as Cell C pain thaws
Levy brothers fall on sword for Cell C
Board changes at Cell C
Blue Label eyes R1bn asset sales to cut debt